Who
Mark A. Gardner
President
Company insider
Files Form 4 as: President, GeneDx Holdings; SVP of Molecular Gen & Oncol, Quest Diagnostics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 23 Feb 2023
- Last trade
- 29 Jun 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jun 2026filed 1 Jul 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —35,441 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —35,441 at $0.00 | filing |
| 24 Sep 2024filed 26 Sep 2024 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $19K120 at $155.70 | filing |
| 28 Feb 2024filed 1 Mar 2024 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $33K262 at $126.36 | filing |
| 14 Feb 2024filed 16 Feb 2024 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —9,376 at $0.00 | filing |
| 14 Feb 2024filed 16 Feb 2024 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —2,250 at $0.00 | filing |
| 25 Sep 2023filed 27 Sep 2023 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $15K116 at $126.22 | filing |
| 23 Feb 2023filed 27 Feb 2023 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —7,584 at $0.00 | filing |
| 23 Feb 2023filed 27 Feb 2023 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —1,919 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.